VEMLIDY is indicated for the treatment of chronic hepatitis B virus (HBV) infection in adults with compensated liver disease.
The Co-pay Savings Program may help your eligible, commercially insured patients lower their out-of-pocket costs.*
Since 2018, over 90% of commercially insured patients enrolled pay $0* with the VEMLIDY Co-pay Savings Programa
Go to Patient EnrollmentFor multilingual assistance call: 1-855-769-7284 Monday–Friday, 9 AM–8 PM ET
Patients enrolled in a government healthcare program such as Medicaid or Medicare Part D are not eligible. This includes patients in the Medicare Part D coverage gap.
*Co-pay savings support is available for commercially insured eligible patients only. Additional restrictions may apply. Subject to change; for full terms and conditions, visit www.mysupportpath.com/providers. This is not health insurance. Only accepted at participating pharmacies.
aData on file as of February 2025. VEMLIDY Co-pay Savings Program. Gilead Sciences, Inc.
Do your patients worry about cost? Insurance or no insurance, Support Path may be able to help.
Support Path provides information to help facilitate patient access to medication. Whether they have insurance or not, Support Path can explore potential coverage options that might be right for them. In some cases, patient consent is required before Support Path can provide assistance.
Support Path can provide information on the following topics:
For multilingual assistance call: 1-855-769-7284 Monday–Friday, 9 AM–8 PM ET
